Edward Joseph Blanchard III

Edward Blanchard practices at Reading Hospital in West Reading, Pennsylvania, part of Tower Health.

Edward Blanchard's NPI, 1770767055, was assigned on December 22, 2007. Edward Blanchard graduated from Perelman School of Med at the University of Pennsylvania in 2004. Edward Blanchard holds Pennsylvania license MD436562.

Edward Blanchard's primary practice is Reading Hospital, at 420 S 5th Avenue, West Reading, PA 19611 in Berks County. The practice phone is (610) 988-8000.

Edward Blanchard's primary practice is Reading Hospital in West Reading, Pennsylvania, part of Tower Health. The medical group on file is Tower Health Medical Group. Dmand AI also links Edward Blanchard to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Edward Blanchard practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Edward Blanchard's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Edward Blanchard is licensed in Pennsylvania.

CMS data shows 748 Medicare services from Edward Blanchard across 4 procedure codes in 2024, for 369 Medicare patients. Medicare paid $55,480 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 369 Medicare patients who saw Edward Blanchard in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Edward Blanchard's median patient age at 63, with 45% women.

In 2024, Edward Blanchard wrote 353 Medicare Part D claims for 85 patients. 74% of them were for generic drugs. CMS names the drug for 228 of them, across 10 drugs with 11 or more claims each, at $277,624 in total drug cost. In 2023, CMS named 167 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Edward Blanchard for performance year 2024, reported as part of a group. Edward Blanchard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Edward Blanchard from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $100.

Edward Blanchard graduated from Perelman School of Med at the University of Pennsylvania in 2004.